No interplay between the pathways mediating coagulation and inflammation in tissue factor-induced disseminated intravascular coagulation in rats

Critical Care Medicine

Volumn 34, Issue 10, 2006, Pages 2646-2650

  Ontachi, Yasuo ^a   Asakura, Hidesaku ^a   Takahashi, Yoko ^a   Hayashi, Tomoe ^a   Arahata, Masahisa ^a   Kadohira, Yasuko ^a   Maekawa, Mio ^a   Omote, Mika ^a   Yoshida, Tomotaka ^a   Yamazaki, Masahide ^a   Morishita, Eriko ^a   Miyamoto, Ken Ichi ^a   Nakao, Shinji ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

Disseminated intravascular coagulation; Interleukin 6; Lipopolysaccharide; Tissue factor; Tumor necrosis factor

Indexed keywords

FIBRINOGEN; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; THROMBIN ANTITHROMBIN COMPLEX; THROMBOPLASTIN; TRANEXAMIC ACID; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD CLOTTING; BLOOD SAMPLING; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISSEMINATED INTRAVASCULAR CLOTTING; HEMOSTASIS; INFLAMMATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; THROMBOCYTE COUNT; VEIN;

ANIMALS; ANTIFIBRINOLYTIC AGENTS; CYTOKINES; DISSEMINATED INTRAVASCULAR COAGULATION; HEMOSTATICS; INTERLEUKIN-10; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MALE; PROSPECTIVE STUDIES; RATS; RATS, WISTAR; RECEPTOR CROSS-TALK; SIGNAL TRANSDUCTION; THROMBOPLASTIN; TRANEXAMIC ACID; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33748794514     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000240228.43264.66     Document Type: Article

References (32)

1. Levi M, Ten Cate H: Disseminated intravascular coagulation. N Engl J Med 1999; 341:586-592
2. Bick RL: Disseminated intravascular coagulation: A review of etiology, pathophysiology, diagnosis, and management: Guidelines for care. Clin Appl Thromb Hemost 2002; 8:1-31
3. Toh CH, Dennis M: Disseminated intravascular coagulation: Old disease, new hope. BMJ 2003; 327:974-977
4. Dempfle CE: Coagulopathy of sepsis. Thromb Haemost 2004; 91:213-224
5. Asakura H, Suga Y, Yoshida T, et al: Pathophysiology of disseminated intravascular coagulation (DIC) progresses at a different rate in tissue factor-induced and lipopolysaccharide-induced DIC models in rats. Blood Coagul Fibrinolysis 2003; 14:221-228
6. Cicala C, Cirino G: Linkage between inflammation and coagulation: An update on the molecular basis of the crosstalk. Life Sci 1998; 62:1817-1824
7. Pawlinski R, Pedersen B, Schabbauer G, et al: Role of tissue factor and protease-activated receptors in a mouse model of endotoxemia. Blood 2004; 103:1342-1347
8. Esmon CT: Crosstalk between inflammation and thrombosis. Maturitas 2004; 47:305-314
9. van der Poll T, Levi M, Hack CE, et al: Elimination of interleukin 6 attenuates coagulation activation in experimental endotoxemia in chimpanzees. J Exp Med 1994; 179:1253-1259
10. Macfarlane SR, Seatter MJ, Kanke T, et al: Proteinase-activated receptors. Pharmacol Rev 2001; 53:245-282
11. Coughlin SR: Thrombin signalling and protease-activated receptors. Nature 2000; 407:258-264
12. Major CD, Santulli RJ, Derian CK, et al: Extracellular mediators in atherosclerosis and thrombosis: Lessons from thrombin receptor knockout mice. Arterioscler Thromb Vasc Biol 2003; 23:931-939
13. Pawlinski R, Mackman N: Tissue factor, coagulation proteases, and protease-activated receptors in endotoxemia and sepsis. Crit Care Med 2004; 32:S293-S297
14. Camerer E, Huang W, Coughlin SR: Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa. Proc Natl Acad Sci U S A 2000; 97:5255-5260
15. Riewald M, Kravchenko VV, Petrovan RJ, et al: Gene induction by coagulation factor Xa is mediated by activation of protease-activated receptor 1. Blood 2001; 97:3109-3116
16. Camerer E, Kataoka H, Kahn M, et al: Genetic evidence that protease-activated receptors mediate factor Xa signaling in endothelial cells. J Biol Chem 2002; 277:16081-16087
17. Riewald M, Ruf W: Mechanistic coupling of protease signaling and initiation of coagulation by tissue factor. Proc Natl Acad Sci U S A 2001; 98:7742-7747
18. Cunningham MA, Rondeau E, Chen X, et al: Protease-activated receptor 1 mediates thrombin-dependent, cell-mediated renal inflammation in crescentic glomerulonephritis. J Exp Med 2000; 191:455-462
19. Lindner JR, Kahn ML, Coughlin SR, et al: Delayed onset of inflammation in protease-activated receptor-2-deficient mice. J Immunol 2000; 165:6504-6510
20. Pelzer H: Determination of human thrombin-antithrombin III complex in human plasma with an enzyme-linked immunosorbent assay. Thromb Haemost 1988; 59:101-106
21. Asakura H, Jokaji H, Saito M, et al: Study of the balance between coagulation and fibrinolysis in disseminated intravascular coagulation using molecular markers. Blood Coagul Fibrinolysis 1994; 5:829-832
22. Asakura H, Okudaira M, Yoshida T, et al: Induction of vasoactive substances differs in LPS-induced and TF-induced DIC models in rats. Thromb Haemost 2002; 88:663-667
23. van Deventer SJ, Buller HR, ten Cate JW, et al: Experimental endotoxemia in humans: Analysis of cytokine release and coagulation, fibrinolytic, and complement pathways. Blood 1990; 76:2520-2526
24. Levi M, ten Cate H, Bauer KA, et al: Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzees. J Clin Invest 1994; 93:114-120
25. de Jonge E, Dekkers PE, Creasey AA, et al: Tissue factor pathway inhibitor dose-dependently inhibits coagulation activation without influencing the fibrinolytic and cytokine response during human endotoxemia. Blood 2000; 95:1124-1129
26. Coletti LM, Remick DG, Burtch GD, et al: Role of tumor necrosis factor- in the pathophysiologic alterations after hepatic ischemia/ reperfusion injury in the rat. J Clin Invest 1990; 85:1936-1943
27. Sakr M, Zetti G, McClain C, et al: The protective effect of FK506 pretreatment against renal ischemia/reperfusion injury in rats. Transplantation 1992; 53:987-991
28. Kelly KJ, Williams WW Jr, Colvin RB, et al: Intercellular adhesion molecule-1-deficient mice are protected against ischemic renal injury. J Clin Invest 1996; 97:1056-1063
29. Ji Q, Zhang L, Jia H, et al: Pentoxifylline inhibits endotoxin-induced NF-kappa B activation and associated production of proinflammatory cytokines. Ann Clin Lab Sci 2004; 34:427-436
30. Coimbra R, Melbostad H, Loomis W, et al: Phosphodiesterase inhibition decreases nuclear factor-kappaB activation and shifts the cytokine response toward anti-inflammatory activity in acute endotoxemia. J Trauma 2005; 59:575-582
31. de Jonge E, Friederich PW, Vlasuk GP, et al: Activation of coagulation by administration of recombinant factor VIIa elicits interleukin 6 (IL-6) and IL-8 release in healthy human subjects. Clin Diagn Lab Immunol 2003; 10:495-497
32. Versteeg HH, Peppelenbosch MP, Spek CA: The pleiotropic effects of tissue factor: A possible role for factor VIIa-induced intracellular signalling? Thromb Haemost 2001; 86:1353-1359